Enrico F.
- Country
- Italy
- Department
- Pediatrics Unit
Research Overview
- Evaluation of Filgotinib Efficacy, Safety, and Pharmacokinetics in Pediatric Patients with Moderate to Severe Ulcerative Colitis
- Phase 3 Multicenter Randomized Study of Guselkumab Efficacy and Safety in Pediatric Patients with Moderate to Severe Crohn's Disease
- Evaluation of Mirikizumab in Pediatric Patients with Moderately to Severely Active Crohn's Disease: A Phase 3 Randomized Multicenter Study
Data & Insights
Has run more than one trial at 26 of 66 partner sites.
Specializations
Inflammatory Bowel Disease Research
Specializes in investigating therapeutic approaches for ulcerative colitis, with particular emphasis on pediatric and adolescent patient populations.
- Pediatric Gastroenterology
- Inflammatory Disease Management
- Therapeutic Innovation
Focuses on evaluating novel treatment modalities for achieving and maintaining disease remission in young patients with inflammatory bowel conditions.
Pediatric Medicine
Conducts research in pediatric and adolescent medicine, specifically addressing chronic inflammatory conditions affecting the digestive system.
- Child and Adolescent Treatment
- Age-Specific Therapeutic Approaches
- Pediatric Drug Development
Investigates treatment efficacy and safety profiles specifically tailored for younger patient populations.
Clinical Immunology
Explores immunological therapeutic approaches in the context of inflammatory bowel disorders, focusing on targeted treatment strategies.
- Immune System Modulation
- Inflammatory Response Management
- Disease Remission Strategies
Studies innovative immunological interventions for chronic inflammatory conditions in pediatric patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.